These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16770110)

  • 81. [Start of a new Working Group on Urological Oncology (AUO) study of prostate cancer].
    Rexer H
    Urologe A; 2005 Aug; 44(8):924. PubMed ID: 16742005
    [No Abstract]   [Full Text] [Related]  

  • 82. Chemotherapy in metastatic, hormone refractory prostatic cancer using chlorambucil in combination with prednisolone versus conjugate, prednimustine (Leo 1031).
    Beckley S; Wajsman LZ; Slack NH; Murphy GP
    Urology; 1981 May; 17(5):446-8. PubMed ID: 7015669
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Predictive value of the clinically and scintigraphically important bone lesions in hormone-refractory prostate cancer (HRPC).
    Zafeirakis A; Limouris GS
    Clin Transl Oncol; 2009 Nov; 11(11):773-4. PubMed ID: 19917544
    [No Abstract]   [Full Text] [Related]  

  • 84. Systemic treatment of hormone refractory prostate cancer.
    Rübben H; Bex A; Otto T
    World J Urol; 2001 Apr; 19(2):99-110. PubMed ID: 11374325
    [No Abstract]   [Full Text] [Related]  

  • 85. Building an Understanding of the Value of Docetaxel Plus Hormone Therapy in Prostate Cancer: An Ever-growing Evidence Base.
    De Abreu Lourenco R; Williams SG
    Eur Urol Oncol; 2018 Dec; 1(6):459-460. PubMed ID: 31158088
    [No Abstract]   [Full Text] [Related]  

  • 86. Selenium supplement in the prevention of pregnancy induced hypertension.
    Han L; Zhou SM
    Chin Med J (Engl); 1994 Nov; 107(11):870-1. PubMed ID: 7867399
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Docetaxel-prednisolone combination therapy for Japanese patients with hormone-refractory prostate cancer: a single institution experience.
    Miura N; Numata K; Kusuhara Y; Shirato A; Hashine K; Sumiyoshi Y
    Jpn J Clin Oncol; 2010 Nov; 40(11):1092-8. PubMed ID: 20587613
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Combination chemotherapy with docetaxel and cisplatin in patients with hormone-refractory prostate cancer].
    Fujinami K; Miura T; Takizawa A; Osada Y
    Hinyokika Kiyo; 2005 Jan; 51(1):5-8. PubMed ID: 15732332
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Docetaxel plus prednisolone for the treatment of metastatic hormone-refractory prostate cancer: a multicenter Phase II trial in Japan.
    Naito S; Tsukamoto T; Koga H; Harabayashi T; Sumiyoshi Y; Hoshi S; Akaza H
    Jpn J Clin Oncol; 2008 May; 38(5):365-72. PubMed ID: 18417502
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Weekly administration of docetaxel in patients with hormone-refractory prostate cancer: a pilot study on Japanese patients.
    Kojima T; Shimazui T; Onozawa M; Tsukamoto S; Hinotsu S; Miyanaga N; Hattori K; Kawai K; Akaza H
    Jpn J Clin Oncol; 2004 Mar; 34(3):137-41. PubMed ID: 15078909
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [A case of hormone-refractory prostate cancer (HRPC) with tumor fever responding to docetaxel plus prednisolone therapy].
    Miura N; Numata K; Azuma K; Hashine K; Sumiyoshi Y
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):841-4. PubMed ID: 16770110
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Treatment of androgen-independent hormone refractory prostate cancer using docetaxel].
    Miyoshi Y; Uemura H; Kubota Y
    Nihon Rinsho; 2005 Feb; 63(2):298-302. PubMed ID: 15714982
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer.
    Collins R; Trowman R; Norman G; Light K; Birtle A; Fenwick E; Palmer S; Riemsma R
    Br J Cancer; 2006 Aug; 95(4):457-62. PubMed ID: 16880788
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Scleroderma-like skin sclerosis induced by docetaxel chemotherapy for hormone refractory prostate cancer: a case report].
    Maehana T; Mizuno T; Muto M; Nishiyama N; Yanase M
    Nihon Hinyokika Gakkai Zasshi; 2010 Sep; 101(6):726-9. PubMed ID: 20954379
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.